Company & Document Details

Shilpa Medicare Limited (Scrip Code: NSE: SHILPAMED/BSE-530549, CIN: L85110KA1987PLC008739) has submitted a notice for its 39th Annual General Meeting to BSE Limited and National Stock Exchange of India Limited. The document date is August 13, 2026, signed by Ritu Tiwary, Company Secretary & Compliance Officer.

Key Dates & Event Details

The 39th Annual General Meeting will be held on Friday, September 11, 2026, at 11:00 A.M. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The cut-off date for determining members entitled to vote is September 4, 2026. The remote e-voting period commences on September 7, 2026, at 09:00 AM and ends on September 10, 2026, at 05:00 PM IST.

Ordinary Business Agenda

1. To receive, consider and adopt the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, together with reports of Board of Directors and Auditors.

2. To declare final dividend of ₹0.60 per equity share for the financial year ended March 31, 2026.

3. To appoint Mr. Sharath Reddy Kalakota (DIN: 03603460) as Director who retires by rotation and offers himself for reappointment.

Special Business Agenda

4. Ratification of remuneration of Cost Auditors: To approve remuneration of ₹75,000 (excluding taxes) plus reimbursement of out-of-pocket expenses to M/s. V.J. Talati & Co, Cost Accountants (Regd. No. M/2203) for auditing cost records for financial year ending March 31, 2027.

5. Payment of Commission to Mr. Madhav Vishnukant Bhutada: To approve payment of commission up to 1% of net profits computed under Section 197 of Companies Act, 2013 to Mr. Madhav Vishnukant Bhutada (DIN: 08222055), Non-Executive Director of Shilpa Biologicals Private Limited (material subsidiary), effective April 1, 2026.

Explanatory Statement Details

Item No. 4: The Board, on recommendations of the Audit Committee, approved the appointment of M/s. V.J. Talati & Co as cost auditors for FY 2026-27. Remuneration requires member ratification as per Section 148 of Companies Act, 2013.

Item No. 5: Mr. Madhav Bhutada has played a significant role in providing strategic leadership and overseeing key business initiatives, particularly in biologics, ADCs and novel biologics. He is the son of Mr. Vishnukant Chaturbhuj Bhutada, Promoter and Managing Director, and holds 40,00,000 equity shares (2.05% of shareholding) in Shilpa Medicare Limited.

Director Details for Reappointment

Mr. Kalakota Sharath Reddy (Age: 58 years, DIN: 03603460):

  • Initial appointment: October 1, 2019
  • Qualification: Bachelor degree in pharmacy from Raichur Gulbarga University and Birla Institute of Technology & Science, Pilani
  • Expertise: 31+ years experience in pharmaceutical API manufacturing, operations, and execution of Greenfield & brownfield projects
  • Shareholding: 56,178 equity shares of Re. 1/- each
  • Board meetings attended during year: 4

Mr. Madhav Vishnukant Bhutada (Age: 31 years, DIN: 08222055):

  • Initial appointment: January 24, 2022 as Managing Director of Shilpa Biocare Private Limited
  • Qualification: B.E Chemical
  • Expertise: 10+ years experience in pharmaceutical industry, focusing on recombinant albumin & large-scale microbial fermentation
  • Shareholding: 40,00,000 equity shares of Re. 1/- each

Meeting Logistics & Voting Procedures

The AGM will be conducted virtually following Ministry of Corporate Affairs General Circular No. 03/2025 dated September 22, 2025, and applicable SEBI Circulars. KFin Technologies Limited has been appointed as Registrar and Transfer Agent to provide Video Conferencing facility.

Members can attend through VC/OAVM using login credentials provided. Physical attendance is not required. Remote e-voting is available through NSDL and CDSL systems for demat holders, and through KFin Technologies for physical shareholders.

Members wishing to speak during the meeting must register by sending a request to cs@vbshilpa.com from September 7, 2026 (09:00 am) to September 8, 2026 (5:00 pm).

Additional Information

The Notice and Annual Report for FY 2025-26 are available on the company's website (https://vbshilpa.com/annual-reports.php) and stock exchange websites. Mr. Santosh Kumar Gunemoni, Partner of VCAN & Associates, has been appointed as Scrutinizer to oversee the e-voting process.